Takeda Pharmaceutical Company LimitedTakeda Pharmaceutical Company LimitedTakeda Pharmaceutical Company Limited

Takeda Pharmaceutical Company Limited

No trades
See on Supercharts

TAK fundamentals

Takeda Pharmaceutical Company Limited financial statements, including revenue, expenses, profit, and loss

The total revenue of TAK for the last quarter is 7.88 B USD, and it's 1.66% higher compared to the previous quarter. The net income of Q2 24 is 616.78 M USD.

Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
‪0.00‬
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: USD
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
TTM
Total revenueYoY growth
Gross profitYoY growth
Pretax incomeYoY growth
Net incomeYoY growth
EBITDAYoY growth
EBITYoY growth